{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:17:54Z","timestamp":1781644674198,"version":"3.54.5"},"reference-count":19,"publisher":"Jaypee Brothers Medical Publishing","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.59556\/japi.74.1361","type":"journal-article","created":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T06:29:12Z","timestamp":1771828152000},"page":"91-93","source":"Crossref","is-referenced-by-count":1,"title":["Bedaquiline-related QTc Prolongation in Multidrug Resistant Tuberculosis Patients: A Prospective Study"],"prefix":"10.59556","volume":"74","author":[{"given":"Ayushi","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher C","family":"Pais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharath","family":"Babu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2914","reference":[{"issue":"(3):","key":"key20260223062905_B1","doi-asserted-by":"crossref","first-page":"463\u2013","DOI":"10.1128\/CMR.16.3.463-496.2003","article-title":"Mycobacterium tuberculosis pathogenesis and molecular determinants of virulence.","volume":"16","author":"Smith","year":"2003;","journal-title":"Clin Microbiol Rev"},{"issue":"(9):","key":"key20260223062905_B2","doi-asserted-by":"crossref","first-page":"a017863.","DOI":"10.1101\/cshperspect.a017863","article-title":"Multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis.","volume":"5","author":"Seung","year":"2015;","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"(1):","key":"key20260223062905_B3","doi-asserted-by":"crossref","first-page":"78\u2013","DOI":"10.4103\/lungindia.lungindia_98_17","article-title":"Multidrug-resistant tuberculosis\/rifampicin resistant tuberculosis: principles of management.","volume":"35","author":"Prasad","year":"2018;","journal-title":"Lung India"},{"key":"key20260223062905_B4","first-page":"4\u2013","volume-title":"India TB Report 2022, Central TB Division, Ministry of Health and Family Welfare.","year":"2022."},{"issue":"(6):","key":"key20260223062905_B5","doi-asserted-by":"crossref","first-page":"2003300.","DOI":"10.1183\/13993003.03300-2020","article-title":"World Health Organization recommendations on the treatment of drug-resistant tuberculosis, 2020 update.","volume":"57","author":"Mirzayev","year":"2021;","journal-title":"Eur Respir J"},{"key":"key20260223062905_B6","doi-asserted-by":"crossref","first-page":"100216.","DOI":"10.1016\/j.jctube.2021.100216","article-title":"Bedaquiline for multidrug-resistant tuberculosis and QTc prolongation in California.","volume":"23:","author":"Katrak","year":"2021;","journal-title":"J Clin Tuberc Other Mycobact Dis"},{"key":"key20260223062905_B7","first-page":"1\u2013","volume-title":"Guidelines for Programmatic Management of Drug Resistant Tuberculosis in India 2021, National TB Elimination Programme, Central TB Division, Ministry of Health and Family Welfare.","year":"2021."},{"issue":"(8):","key":"key20260223062905_B8","doi-asserted-by":"crossref","first-page":"2951.","DOI":"10.3390\/s22082951","article-title":"Monitoring of serum potassium and calcium levels in end-stage renal disease patients by ECG depolarization morphology analysis.","volume":"22","author":"Bukhari","year":"2022;","journal-title":"Sensors (Basel)"},{"issue":"(7):","key":"key20260223062905_B9","doi-asserted-by":"crossref","first-page":"975\u2013","DOI":"10.1016\/S1473-3099(20)30770-2","article-title":"QT effects of bedaquiline, delamanid, or both in patients with rifampicin-resistant tuberculosis: a phase 2, open-label, randomised, controlled trial.","volume":"21","author":"Dooley","year":"2021;","journal-title":"Lancet Infect Dis"},{"issue":"(8):","key":"key20260223062905_B10","doi-asserted-by":"crossref","first-page":"723\u2013","DOI":"10.1056\/NEJMoa1313865","article-title":"Multidrug-resistant tuberculosis and culture conversion with bedaquiline.","volume":"371","author":"Diacon","year":"2014;","journal-title":"N Engl J Med"},{"issue":"(12):","key":"key20260223062905_B11","first-page":"1603\u2013","article-title":"Antimicrobial-associated QT interval prolongation: pointes of interest.","volume":"43","author":"Owens","year":"2006;","journal-title":"Clin Infect Dis"},{"issue":"(10):","key":"key20260223062905_B12","doi-asserted-by":"crossref","first-page":"1013\u2013","DOI":"10.1056\/NEJMra032426","article-title":"Drug-induced prolongation of the QT interval.","volume":"350","author":"Roden","year":"2004;","journal-title":"N Engl J Med"},{"issue":"(1):","key":"key20260223062905_B13","doi-asserted-by":"crossref","first-page":"29\u2013","DOI":"10.1016\/j.ijtb.2019.10.002","article-title":"Effectiveness and safety of bedaquiline under conditional access program for treatment of drug-resistant tuberculosis in India: an interim analysis.","volume":"67","author":"Salhotra","year":"2020;","journal-title":"Indian J Tuberc"},{"issue":"(1):","key":"key20260223062905_B14","doi-asserted-by":"crossref","first-page":"32.","DOI":"10.1186\/s40249-021-00819-2","article-title":"Bedaquiline-containing regimens in patients with pulmonary multidrug-resistant tuberculosis in China: focus on the safety.","volume":"10","author":"Gao","year":"2021;","journal-title":"Infect Dis Poverty"},{"issue":"(5):","key":"key20260223062905_B15","doi-asserted-by":"crossref","first-page":"1701462.","DOI":"10.1183\/13993003.01462-2017","article-title":"Cardiac safety of bedaquiline: a systematic and critical analysis of the evidence.","volume":"50","author":"Pontali","year":"2017;","journal-title":"Eur Respir J"},{"issue":"(8):","key":"key20260223062905_B16","doi-asserted-by":"crossref","first-page":"ofab413.","DOI":"10.1093\/ofid\/ofab413","article-title":"QT interval prolongation in people treated with bedaquiline for drug-resistant tuberculosis under programmatic conditions: a retrospective cohort study.","volume":"8","author":"Isralls","year":"2021;","journal-title":"Open Forum Infect Dis"},{"issue":"(3):","key":"key20260223062905_B17","first-page":"140\u2013","article-title":"Bedaquiline correlation to QT interval prolongation in DR-TB patients.","volume":"8","author":"Primadana","year":"2022;","journal-title":"J Respirol"},{"issue":"(2):","key":"key20260223062905_B18","doi-asserted-by":"crossref","first-page":"188\u2013","DOI":"10.1093\/cid\/ciu786","article-title":"Compassionate use of bedaquiline for the treatment of multidrug-resistant and extensively drug-resistant tuberculosis: interim analysis of a French cohort.","volume":"60","author":"Guglielmetti","year":"2015;","journal-title":"Clin Infect Dis"},{"issue":"(3):","key":"key20260223062905_B19","first-page":"389\u2013","article-title":"Bedaquiline effect on QT interval of drugs-resistant tuberculosis patients: real world data.","volume":"54","author":"Darmayani","year":"2022;","journal-title":"Acta Med Indones"}],"container-title":["Journal of The Association of Physicians of India"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T06:29:15Z","timestamp":1771828155000},"score":1,"resource":{"primary":{"URL":"https:\/\/japi.org\/article\/japi-74-2-91"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["10.59556\/japi.74.1361"],"URL":"https:\/\/doi.org\/10.59556\/japi.74.1361","relation":{},"ISSN":["0004-5772"],"issn-type":[{"value":"0004-5772","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]}}}